Patent ID: 6664289
Filing Date: 2003-12-16
Classification: A61K

Abstract:
A method of reducing the risk of microbial infection or of combating a microbial infection which is established first in the nasal mucosa area comprising:the application of a nasal spray solution within the nose, said nasal spray solution comprising an aqueous solution having the following components: a) sodium hypochlorite, potassium hypochlorite, or calcium hypochlorite in a concentration of about 0.5 ppmw to about 50,000 ppmw; b) sodium chloride, magnesium chloride, calcium chloride or potassium chloride in a concentration of about 55 ppmw to 75,000 ppmw; c) sodium bromide, magnesium bromide, calcium bromide or potassium bromide in a concentration of about 0.7 ppmw to about 140,000 ppmw; d) sodium iodide, magnesium iodide, calcium iodide or potassium iodide in a concentration of about 0.1 ppmw to about 160,000 ppmw; e) chlorine in a concentration of about 0.4 ppmw to about 50,000 ppmw; f) bromine in a concentration of about 1 ppmw to about 75,000 ppmw; g) zinc chloride in a concentration of about 0.4 ppmw to about 50,000 ppmw; h) zinc bromide in a concentration of about 0.7 ppmw to about 80,000 ppmw; and i) zinc iodide in a concentration of about 1 ppmw to about 120,000 ppmw; and optionally one or more of zinc gluconate in a concentration of about 1.7 ppmw to about 60,000 ppmw, and glycerine or propylene glycol in a concentration of about 0.01 wt % to about 5 wt %.